Cluvot

Cluvot is a pharmaceutical product containing Human Coagulation Factor XIII, used for managing bleeding disorders. This intravenous medication supports blood clotting and is manufactured by CSL Behring GmbH.

Cluvot is primarily used to treat bleeding disorders by aiding in blood clotting. It is often prescribed for individuals with congenital Factor XIII deficiency, a condition that impairs the blood's ability to clot properly. The medication helps to prevent excessive bleeding and supports wound healing.

Common effects of Cluvot may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild flu-like symptoms, including fever or chills. These effects are generally temporary and should be monitored.

Cluvot should be handled with care, ensuring proper storage and administration by healthcare professionals. Patients with known allergies to Factor XIII or any components of the medication should avoid its use. Regular monitoring may be required to assess the body's response to the treatment.

Cluvot may interact with other medications that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare professional, as it may influence the effectiveness of the treatment.